A major study published in PLOS Digital Health reveals that retinal scans can detect structural biomarkers of atrial fibrillation up to four years before clinical diagnosis. Led by Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology, researchers analyzed over 90,000 eye scans to identify nerve cell thinning linked to the common heart rhythm disorder.
Atrial fibrillation (AF) stands as the most prevalent heart rhythm disorder, impacting over 1.5 million people across the UK alone. The condition substantially elevates the risk of stroke, heart failure, and death. Because AF often manifests intermittently, standard electrocardiograms (ECGs) frequently miss early-stage arrhythmias. Consequently, many patients remain undiagnosed until a serious or life-threatening complication occurs. A team of researchers set out to determine whether non-invasive optical coherence tomography (OCT) imaging, already standard in community optometry, could bridge this diagnostic gap.
In Plain English: The Clinical Takeaway
- The Test: Routine eye scans—specifically optical coherence tomography (OCT)—can measure microscopic layers of nerve cells at the back of the eye.
- The Discovery: People with atrial fibrillation consistently show thinning in the macular ganglion cell and inner plexiform layer (mGCIPL), a neural connection between the eye and brain.
- The Timeline: These structural retinal alterations appear roughly four years before patients experience clinical symptoms or receive a formal hospital diagnosis.
Unpacking the Data: Inside the Moorfields and UK Biobank Cohorts
The research team utilized two massive datasets to establish statistical significance. The first, the AlzEye dataset from Moorfields, encompassed over 50,000 patients, of whom 5,735 had a pre-existing AF diagnosis. The second cohort drew from the UK Biobank, covering approximately 40,000 participants, including 526 individuals with AF. Across both cohorts, researchers observed a clear morphological correlation: thinner mGCIPL layers corresponded directly with a higher probability of an atrial fibrillation diagnosis.
Crucially, when tracking patients who did not have AF at the time of their initial imaging, those who subsequently developed the condition exhibited thinner mGCIPL layers an average of four years prior to presentation. This correlation held strong even after adjusting for confounding variables such as age, sex, ethnicity, hypertension, diabetes, smoking status, and alcohol consumption. The authors propose that the thinning observed in people who developed or had AF could indicate mini strokes in the brain that typically occur as a result of AF before its diagnosis, which reduce blood flow to the retinal nerve cells.
Senior author Siegfried Wagner noted the clinical potential of utilizing existing infrastructure:
“This large-scale analysis shows that retinal imaging can pick up on structural changes within the eye that are clearly linked to AF. For patients, the value of this kind of eye imaging is that it is easy to access, quick and doesn’t involve any invasive procedures. Although not intended to replace ECG-based diagnosis, retinal imaging could act as a complementary tool, catching those most at risk of AF before it causes real harm.” Siegfried Wagner
Meanwhile, patient accounts underscore the human cost of delayed detection. For instance, Moorfields patient John Brewer was diagnosed with AF unexpectedly while under sedation during a routine cataract operation, highlighting how easily asymptomatic arrhythmias evade standard clinical paths until a surgical team intervenes with an ECG.
| Dataset Source | Total Participants Analyzed | Confirmed AF Cases | Key Retinal Biomarker Identified |
|---|---|---|---|
| AlzEye Cohort (Moorfields) | >50,000 | 5,735 | Thinner mGCIPL (macular ganglion cell-inner plexiform layer) |
| UK Biobank Cohort | ~40,000 | 526 | Thinner mGCIPL observed up to 4 years pre-diagnosis |
Contraindications & When to Consult a Doctor
While non-invasive retinal imaging offers an avenue for risk stratification, patients must understand its current limitations. OCT scans are not diagnostic tools for cardiac arrhythmias on their own; they cannot replace an ECG. Individuals experiencing symptoms should seek evaluation by a healthcare provider.
References
- PLOS Digital Health: Retinal imaging and cardiovascular biomarkers study by Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.
Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any health condition or clinical symptoms.
Keep reading
- UN sees some progress in Congo Ebola fight, but too early to call peak
- Trump Administration Backs Psychedelics: FDA Approval and Delivery Challenges
- Why Virginia and New Jersey Elect Their Governors in Odd Years (daybreakwire.com)
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
